Ultragenyx Pharmaceutical Inc. Purchase Agreements
4 Contracts & Agreements
- Royalty Purchase Agreement by and among Rare Delaware Inc., Ultragenyx Pharmaceutical Inc. and OCM LS23 Holdings LP dated as of July 14, 2022 (Filed With SEC on July 29, 2022)
- Equity Purchase Agreement, dated as of June 18, 2019 by and among Ultragenyx Pharmaceutical Inc. and Arcturus Therapeutics Ltd (Filed With SEC on July 31, 2020)
- Royalty Purchase Agreement, dated as of December 17, 2019, between Ultragenyx Pharmaceutical Inc. and RPI Finance Trust (Filed With SEC on February 14, 2020)
- Asset Purchase Agreement, dated December 14, 2017, among Ultragenyx Pharmaceutical Inc., Ultragenyx International UX003 Ltd. and Novartis Pharma AG (Filed With SEC on February 21, 2018)
